VCYT FY 2016 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+31.5% YoY

Gross Profit

$40M60.9% margin

Operating Income

-$29M-44.3% margin

Net Income

-$31M-48.2% margin

EPS (Diluted)

$-1.09

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$32M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$101M

Total Liabilities

$41M

Stockholders' Equity

$60M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$50M	+31.5%
Gross Profit	$40M	$28M	+41.5%
Operating Income	-$29M	-$33M	+13.9%
Net Income	-$31M	-$34M	+7.0%